We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New High-Vacuum Pump Provides Increased Reliability and Efficiency

By LabMedica International staff writers
Posted on 19 Feb 2013
A new, high-performance turbomolecular pump is the first high-vacuum pump featuring a novel floating-suspension system that enables dramatic improvements over current technology.

Agilent Technologies (Santa Clara, CA, USA) introduces the TwisTorr 304 FS vacuum pump for use in a variety of applications and markets, including academic and government research, and the analytical, industrial, and nanotech/semiconductor industries. More...
Running at 60,000 rpm, it pumps up to 250 L/s for N2. It also provides dramatic improvements in reliability and increases light gas compression ratios 100-fold. TwisTorr drag stages guarantee high pumping speed and compression ratios for hydrogen and helium. The pump also provides unparalleled throughput and high foreline tolerance, as well as low power-consumption and operating temperature.

Coupled with the same superior performance as in Agilent’s existing line of patented TwisTorr solutions, the new system's breakthrough floating-suspension technology ensures low vibration and acoustical noise, optimal working conditions for the bearings, extended operating life, and exceptional stability for demanding applications and instruments such as scanning electron microscopes. It also features a compact rotor design that reduces power consumption and system footprint. Its unique bearing and dry lubricated suspension system is maintenance-free, eliminates oil and risk of contamination, and permits installation in multiple orientations.

"The new TwisTorr 304 FS is the smallest, most reliable, and energy-efficient high-vacuum pump available today," said Giampaolo Levi, vice president and general manager of Agilent's Vacuum Products Division; "[...] and we will continue our active collaboration with customers to identify their expanding needs and develop new advances in turbo pump design."

Related Links:
Agilent Technologies, Inc.
Agilent TwisTorr 304 FS


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
POC Immunoassay Analyzer
Procise DX
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.